Protein degraders enter the clinic—a new approach to cancer therapy

D Chirnomas, KR Hornberger, CM Crews - Nature Reviews Clinical …, 2023 - nature.com
Heterobifunctional protein degraders, such as PROteolysis TArgeting Chimera (PROTAC)
protein degraders, constitute a novel therapeutic modality that harnesses the cell's natural …
被引用次数：149 相关文章

Protein degraders enter the clinic-a new approach to cancer therapy.

D Chirnomas, KR Hornberger… - Nature reviews. Clinical …, 2023 - europepmc.org
Heterobifunctional protein degraders, such as PROteolysis TArgeting Chimera (PROTAC)
protein degraders, constitute a novel therapeutic modality that harnesses the cell's natural …

Protein degraders enter the clinic-a new approach to cancer therapy

D Chirnomas, KR Hornberger… - Nature reviews …, 2023 - pubmed.ncbi.nlm.nih.gov
Heterobifunctional protein degraders, such as PROteolysis TArgeting Chimera (PROTAC)
protein degraders, constitute a novel therapeutic modality that harnesses the cell's natural …
[PDF] arvinasoncologymedical.com

[PDF][PDF] Protein degraders enter the clinic—a new approach to cancer therapy

D Chirnomas, KR Hornberger, CM Crews - arvinasoncologymedical.com
Heterobifunctional protein degraders, such as PROteolysis TArgeting Chimera (PROTAC)
protein degraders, constitute a novel therapeutic modality that harnesses the cell's natural …

[引用][C] Protein degraders enter the clinic—a new approach to cancer therapy

D Chirnomas, KR Hornberger, CM Crews - Nature Reviews Clinical …, 2023 - cir.nii.ac.jp
Protein degraders enter the clinic — a new approach to cancer therapy | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF] yuntsg.com

[PDF][PDF] Protein degraders enter the clinic—a new approach to cancer therapy

D Chirnomas, KR Hornberger, CM Crews - bookcafe.yuntsg.com
Conclusions 1Arvinas Operations, Inc., New Haven, CT, USA. 2Department of Molecular,
Cellular & Developmental Biology, Yale University, New Haven, CT, USA. 3Department of …